News
Sandvik unveils its 'Advancing to 2030' strategy, aiming to embed sustainability and digitalisation within its manufacturing operations ...
Top FDA official Vinay Prasad recently drew outrage from conservatives, including Laura Loomer, who disagreed with his approach to approving gene therapies for rare diseases and accused him of holding ...
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...
Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...
11h
MyChesCo on MSNAclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific OfficerAclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
Vinay Prasad, the U.S. Food and Drug Administration's chief medical and science officer, has left the health regulator, the U ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results